Total Payments
$8,913
2024 Payments
$1,291
Companies
48
Transactions
474
Medicare Patients
3,309
Medicare Billing
$276,219
Payment Breakdown by Category
Food & Beverage$7,706 (86.5%)
Travel$1,058 (11.9%)
Education$148.58 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,706 | 467 | 86.5% |
| Travel and Lodging | $1,058 | 3 | 11.9% |
| Education | $148.58 | 4 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,361 | 108 | $0 (2024) |
| Covidien LP | $1,170 | 12 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $865.01 | 50 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $588.68 | 34 | $0 (2024) |
| United Therapeutics Corporation | $520.04 | 19 | $0 (2024) |
| Genentech USA, Inc. | $472.08 | 33 | $0 (2022) |
| Insmed, Inc. | $435.08 | 21 | $0 (2024) |
| Grifols USA, LLC | $421.83 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $354.74 | 24 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $296.44 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,291 | 70 | GlaxoSmithKline, LLC. ($195.90) |
| 2023 | $1,264 | 63 | GlaxoSmithKline, LLC. ($314.64) |
| 2022 | $1,140 | 70 | GlaxoSmithKline, LLC. ($202.02) |
| 2021 | $585.29 | 38 | GlaxoSmithKline, LLC. ($112.87) |
| 2020 | $1,538 | 34 | Covidien LP ($1,170) |
| 2019 | $1,167 | 79 | Boehringer Ingelheim Pharmaceuticals, Inc. ($232.76) |
| 2018 | $622.24 | 41 | GlaxoSmithKline, LLC. ($146.26) |
| 2017 | $1,305 | 79 | GlaxoSmithKline, LLC. ($201.14) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Airway Clearance Device | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Airway Clearance Device | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Pulmonology | ||||||
| 10/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Immunology | ||||||
| 10/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Pulmonology | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 837 | 1,149 | $224,705 | $67,226 |
| 2022 | 9 | 838 | 1,211 | $185,055 | $69,625 |
| 2021 | 13 | 899 | 1,208 | $195,430 | $69,328 |
| 2020 | 13 | 735 | 996 | $214,550 | $70,040 |
Total Patients
3,309
Total Services
4,564
Medicare Billing
$276,219
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 174 | 352 | $147,980 | $45,017 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 112 | $32,900 | $9,745 | 29.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $24,440 | $7,097 | 29.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 151 | 204 | $4,605 | $1,233 | 26.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 146 | 199 | $4,170 | $1,093 | 26.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 19 | 32 | $2,560 | $774.91 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,580 | $739.64 | 28.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 54 | 54 | $1,620 | $453.25 | 28.0% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 31 | 35 | $1,395 | $414.12 | 29.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 46 | 48 | $960.00 | $314.43 | 32.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 42 | 43 | $860.00 | $258.72 | 30.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $635.00 | $85.25 | 13.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 161 | 284 | $69,940 | $37,678 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 134 | $22,110 | $12,717 | 57.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 74 | 74 | $31,480 | $11,733 | 37.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 45 | 134 | $8,770 | $3,360 | 38.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 158 | 232 | $25,520 | $1,500 | 5.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 135 | 209 | $14,630 | $1,239 | 8.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 72 | 72 | $7,920 | $654.38 | 8.3% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 42 | 45 | $1,580 | $527.88 | 33.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 27 | 27 | $3,105 | $216.06 | 7.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 106 | 215 | $52,675 | $27,947 | 53.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 60 | 131 | $26,200 | $10,392 | 39.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 55 | 55 | $23,100 | $9,305 | 40.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 52 | $19,760 | $7,991 | 40.4% |
About Dr. Jared Kravitz, MD
Dr. Jared Kravitz, MD is a Pulmonary Disease healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427105212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jared Kravitz, MD has received a total of $8,913 in payments from pharmaceutical and medical device companies, with $1,291 received in 2024. These payments were reported across 474 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,706).
As a Medicare-enrolled provider, Kravitz has provided services to 3,309 Medicare beneficiaries, totaling 4,564 services with total Medicare billing of $276,219. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Knoxville, TN
- Active Since 01/04/2007
- Last Updated 07/22/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1427105212
Products in Payments
- TRELEGY ELLIPTA (Drug) $713.17
- Puritan Bennett (Device) $546.28
- OFEV (Drug) $524.99
- Arikayce (Drug) $435.08
- ACTHAR (Biological) $392.05
- NUCALA (Biological) $367.41
- Xolair (Biological) $316.08
- Prolastin-C Liquid (Biological) $300.04
- UPTRAVI (Drug) $271.21
- TYVASO (Drug) $250.85
- ZERBAXA (Drug) $227.70
- ORENITRAM (Drug) $223.22
- AVYCAZ (Drug) $220.36
- STIOLTO RESPIMAT (Drug) $199.05
- OPSUMIT (Drug) $188.96
- DUPIXENT (Biological) $161.75
- ANORO (Drug) $152.43
- Esbriet (Biological) $138.94
- OPSUMIT MACITENTAN (Drug) $128.51
- Prolastin-C (Biological) $121.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Knoxville
Prof. Rajiv Dhand, Md, MD
Pulmonary Disease — Payments: $255,078
Pulmonary Disease $255,078
Dr. Varun Shah
Pulmonary Disease — Payments: $39,294
Pulmonary Disease $39,294
J. Turner, Md, MD
Pulmonary Disease — Payments: $15,733
Pulmonary Disease $15,733
Paul Branca, Md, MD
Pulmonary Disease — Payments: $8,504
Pulmonary Disease $8,504
Elise Schriver, M.d, M.D
Pulmonary Disease — Payments: $8,131
Pulmonary Disease $8,131
Dr. Bashar Bargoty, Md, MD
Pulmonary Disease — Payments: $7,758
Pulmonary Disease $7,758